Global Vascular Grafts Market

Vascular Grafts Market Size, Share, Growth Analysis, By Raw Material (Polyester Grafts, ePTFE), By Indication (Endovascular Aneurysm Repair, Abdominal Aortic Aneurysms Repair), By End User (Hospitals, and Ambulatory Surgical Centers), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2177 | Region: Global | Published Date: September, 2024
Pages: 242 | Tables: 120 | Figures: 68

Vascular Grafts Market Insights

Global Vascular Grafts Market size was valued at around USD 1.5 billion in 2022 and is expected to rise from USD 1.6 billion in 2023 to reach a value of USD 2.8 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).

Increasing prevalence of health conditions like chronic kidney and cardiovascular diseases is propelling the use of vascular grafts. The demand for vascular graft surgeries or procedures is being driven by the increase in lifestyle-related disorders, surge in the geriatric population, increase in health care spending, and improvement in healthcare infrastructure. Governments and regulatory agencies around the world are implementing cost-containment strategies to ease the burden of health care, particularly in developed economies. Governments, healthcare providers, insurance payers, and life sciences companies have all taken different actions that have contributed to the transition from a volume-based to a value-based system.

US Vascular Grafts Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Vascular Grafts Market size was valued at around USD 1.5 billion in 2022 and is expected to rise from USD 1.6 billion in 2023 to reach a value of USD 2.8 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).

Global vascular grafts market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Medtronic ', 'Terumo ', 'C. R. Bard ', 'B. Braun Melsungen AG ', 'Cardinal Health ', 'Endologix ', 'LeMaitre Vascular ', 'Cook Medical ', 'Maquet ', 'Gore Medical'

One of the main risk factors for diabetes, hypertension, cardiovascular diseases, and other diseases is chronic kidney disease (CKD), also known as chronic kidney failure. It involves a progressive decline in kidney function. Advanced chronic kidney disease can cause the body to accumulate hazardous amounts of fluids, electrolytes, and waste. Over 37 million adults in the U.S. have CKD, according to the National Institute of Diabetes and Digestive and Kidney Diseases. The prevalence of cardiovascular disorders is increased by hereditary factors, alcohol and tobacco use, and lifestyle choices. The WHO estimates that 17.9 million deaths worldwide in 2019 were caused by cardiovascular diseases (CVDs), or 32% of all deaths. About 85% of these were caused by heart attacks and strokes. Additionally, as more people are diagnosed with cancer, there is a greater need for implantable ports & grafts and central venous catheters to administer chemotherapy drugs and blood transfusions.

The adoption of the MIDCAB procedure has increased due to the rising demand for minimally invasive procedures and its safety and low mortality rate. Additionally, it is compatible with cardiopulmonary bypass and aortic cross-clamp. Additionally, it is anticipated that in the coming years, the development of surgical procedures utilizing coronary artery stent grafts will increase demand for vascular grafts.

North America accounted for a major global vascular graft market share in 2021, due to increasing health consciousness and the accessibility of cardiovascular treatment facilities within the region. Furthermore, the existence of reimbursement guidelines and the use of sophisticated technological procedures are also driving market expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Vascular Grafts Market

Report ID: SQMIG35A2177

$5,300
BUY NOW GET FREE SAMPLE